Nobuko Ohmoto
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 8
-
- Epigenetics and DNA Methylation 1
- DNA Repair Mechanisms 1
- Cancer therapeutics and mechanisms 1
- Genomics, phytochemicals, and oxidative stress 1
- Co-authors
- Katsuhiko Okumura (11 shared papers)Toshiyuki Sakaeda (11 shared papers)Tsutomu Nakamura (9 shared papers)Masanori Horinouchi (3 shared papers)Takao Tamura (2 shared papers)Midori Hirai (4 shared papers)Kohji Takara (7 shared papers)Nobuo Aoyama (2 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (3 papers)Pharmaceutical Research (2 papers)European Journal of Pharmaceutical Sciences (1 paper)Critical Care Medicine (1 paper)Journal of Pharmacy and Pharmacology (1 paper)
- Partner nations
- JapanNew Zealand
In The Last Decade
Nobuko Ohmoto
13 papers receiving 763 citations
Peers
Comparison fields: 5 of 86
- Oncology 422
- Pharmacology 139
- Pediatrics, Perinatology and Child Health 196
- Critical Care and Intensive Care Medicine 27
- Transplantation 14
Countries citing papers authored by Nobuko Ohmoto
This map shows the geographic impact of Nobuko Ohmoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuko Ohmoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuko Ohmoto more than expected).
Fields of papers citing papers by Nobuko Ohmoto
This network shows the impact of papers produced by Nobuko Ohmoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuko Ohmoto. The network helps show where Nobuko Ohmoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Nobuko Ohmoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 268 | |
| 2 | 2002 | 113 | |
| 3 | 2002 | 88 | |
| 4 | 2000 | 85 | |
| 5 | 2002 | 46 | |
| 6 | 2002 | 45 | |
| 7 | 2001 | 35 | |
| 8 | 2002 | 32 | |
| 9 | 2003 | 27 | |
| 10 | 2003 | 20 | |
| 11 | 2022 | 11 | |
| 12 | 2008 | 7 | |
| 13 | 2008 | 3 |
About Nobuko Ohmoto
Nobuko Ohmoto is a scholar working on Oncology, Molecular Biology, Pharmacology, Surgery and Cancer Research, having authored 13 papers that have together received 780 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (3 papers), Estrogen and related hormone effects (1 paper), Epigenetics and DNA Methylation (1 paper), DNA Repair Mechanisms (1 paper), Intensive Care Unit Cognitive Disorders (1 paper), Cancer therapeutics and mechanisms (1 paper) and Genomics, phytochemicals, and oxidative stress (1 paper). The work is most often cited by research in Oncology (422 citations), Pharmacology (139 citations), Pediatrics, Perinatology and Child Health (196 citations), Critical Care and Intensive Care Medicine (27 citations) and Transplantation (14 citations). Nobuko Ohmoto has collaborated with scholars based in Japan and New Zealand. Frequent co-authors include Katsuhiko Okumura, Toshiyuki Sakaeda, Tsutomu Nakamura, Masanori Horinouchi, Takao Tamura, Midori Hirai, Kohji Takara, Nobuo Aoyama, Masato Kasuga and Mikio Kakumoto. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Critical Care Medicine and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.